首页 > 最新文献

Chinese Medical Sciences Journal最新文献

英文 中文
“Typhoidal Cells” Appear in a Woman with Hemophagocytic Syndrome Secondary To Brucellosis: A Case Report “伤寒细胞”出现在一例布鲁氏菌病继发性吞噬细胞综合征妇女身上
Q2 Medicine Pub Date : 2023-03-01 DOI: 10.24920/004152
Wei-Qing Song , Xu Zheng , Hai-Ni Li , Li Li , Jiang-Shui Yuan , Shu-Guo Wang

We report a case of hemophagocytic syndrome (HPS) secondary to brucellosis, in which typhoidal cells were found in bone marrow, suggesting typhoidal cells present not only in Salmonella typhi infections but also in other bacterial infections. Typhoidal cells in bone marrow can be used to quickly identify the presence of bacterial infection pending the results of bone marrow and/or blood cultures.

我们报告了一例继发于布鲁氏菌病的噬血细胞综合征(HPS),在骨髓中发现了伤寒细胞,这表明伤寒细胞不仅存在于伤寒沙门氏菌感染中,也存在于其他细菌感染中。骨髓中的伤寒细胞可用于在骨髓和/或血液培养结果出来之前快速鉴定细菌感染的存在。
{"title":"“Typhoidal Cells” Appear in a Woman with Hemophagocytic Syndrome Secondary To Brucellosis: A Case Report","authors":"Wei-Qing Song ,&nbsp;Xu Zheng ,&nbsp;Hai-Ni Li ,&nbsp;Li Li ,&nbsp;Jiang-Shui Yuan ,&nbsp;Shu-Guo Wang","doi":"10.24920/004152","DOIUrl":"10.24920/004152","url":null,"abstract":"<div><p>We report a case of hemophagocytic syndrome (HPS) secondary to brucellosis, in which typhoidal cells were found in bone marrow, suggesting typhoidal cells present not only in <em>Salmonella typhi</em> infections but also in other bacterial infections. Typhoidal cells in bone marrow can be used to quickly identify the presence of bacterial infection pending the results of bone marrow and/or blood cultures.</p></div>","PeriodicalId":35615,"journal":{"name":"Chinese Medical Sciences Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9313207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances in Medical Treatment of Primary Aldosteronism 原发性醛固酮增多症的医学治疗进展
Q2 Medicine Pub Date : 2023-03-01 DOI: 10.24920/004137
Ying-Jie Li, Zhi-Gang Ji, Jin Wen

Primary aldosteronism (PA) is the most common form of secondary hypertension, with its main manifestations including hypertension and hypokalemia. Early identification of PA is extremely important as PA patients can easily develop cardiovascular complications such as atrial fibrillation, stroke, and myocardial infarction. The past decade has witnessed the rapid advances in the genetics of PA, which has shed new light on PA treatment. While surgery is the first choice for unilateral diseases, bilateral lesions can be treated with mineralocorticoid receptor antagonists (MRAs). The next-generation non-steroidal MRAs are under investigations. New medications including calcium channel blockers, macrophage antibiotics, and aldosterone synthase inhibitors have provided a new perspective for the medical treatment of PA.

原发性醛固酮增多症(PA)是继发性高血压最常见的形式,其主要表现包括高血压和低钾血症。PA的早期识别非常重要,因为PA患者很容易出现心血管并发症,如心房颤动、中风和心肌梗死。过去十年见证了PA遗传学的快速发展,这为PA的治疗提供了新的线索。虽然手术是单侧疾病的首选,但双侧病变可以用盐皮质激素受体拮抗剂(MRAs)治疗。下一代非甾体MRA正在研究中。包括钙通道阻滞剂、巨噬细胞抗生素和醛固酮合成酶抑制剂在内的新药为PA的医学治疗提供了新的视角。
{"title":"Advances in Medical Treatment of Primary Aldosteronism","authors":"Ying-Jie Li,&nbsp;Zhi-Gang Ji,&nbsp;Jin Wen","doi":"10.24920/004137","DOIUrl":"10.24920/004137","url":null,"abstract":"<div><p>Primary aldosteronism (PA) is the most common form of secondary hypertension, with its main manifestations including hypertension and hypokalemia. Early identification of PA is extremely important as PA patients can easily develop cardiovascular complications such as atrial fibrillation, stroke, and myocardial infarction. The past decade has witnessed the rapid advances in the genetics of PA, which has shed new light on PA treatment. While surgery is the first choice for unilateral diseases, bilateral lesions can be treated with mineralocorticoid receptor antagonists (MRAs). The next-generation non-steroidal MRAs are under investigations. New medications including calcium channel blockers, macrophage antibiotics, and aldosterone synthase inhibitors have provided a new perspective for the medical treatment of PA.</p></div>","PeriodicalId":35615,"journal":{"name":"Chinese Medical Sciences Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9320727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Cannabinoid CB1, Receptor in Object Recognition Memory Impairment in Chronically Rapid Eye Movement Sleep-deprived Rats 大麻酚CB1受体在慢性快速眼动睡眠剥夺大鼠物体识别记忆障碍中的作用
Q2 Medicine Pub Date : 2023-03-01 DOI: 10.24920/004087
Kaveh Shahveisi , Seyedeh Marziyeh Hadi , Hamed Ghazvini , Mehdi Khodamoradi

Objective

We aimed to investigate whether antagonism of the cannabinoid CB1 receptor (CB1R) could affect novel object recognition (NOR) memory in chronically rapid eye movement sleep-deprived (RSD) rats.

Methods

The animals were examined for recognition memory following a 7-day chronic partial RSD paradigm using the multiple platform technique. The CB1R antagonist rimonabant (1 or 3 mg/kg, i.p.) was administered either at one hour prior to the sample phase for acquisition, or immediately after the sample phase for consolidation, or at one hour before the test phase for retrieval of NOR memory. For the reconsolidation task, rimonabant was administered immediately after the second sample phase.

Results

The RSD episode impaired acquisition, consolidation, and retrieval, but it did not affect the reconsolidation of NOR memory. Rimonabant administration did not affect acquisition, consolidation, and reconsolidation; however, it attenuated impairment of the retrieval of NOR memory induced by chronic RSD.

Conclusions

These findings, along with our previous report, would seem to suggest that RSD may affect different phases of recognition memory based on its duration. Importantly, it seems that the CB1R may, at least in part, be involved in the adverse effects of chronic RSD on the retrieval, but not in the acquisition, consolidation, and reconsolidation, of NOR memory.

目的研究大麻素CB1受体(CB1R)的拮抗作用是否会影响慢性快速眼动睡眠剥夺(RSD)大鼠的新物体识别(NOR)记忆。方法采用多平台技术,按照7天的慢性部分RSD模式对动物进行识别记忆检查。CB1R拮抗剂利莫那班(1或3 mg/kg,i.p.)在采集样本期前一小时,或在巩固样本期后立即给药,或在恢复NOR记忆的测试期前一个小时给药。对于再固结任务,利莫那班在第二个样品阶段后立即给药。结果RSD发作损害了NOR记忆的获取、巩固和检索,但不影响NOR记忆再巩固。里莫纳班特管理并未影响收购、合并和再合并;然而,它减轻了慢性RSD引起的NOR记忆检索损伤。结论这些发现以及我们之前的报告似乎表明,RSD可能会根据其持续时间影响识别记忆的不同阶段。重要的是,CB1R似乎至少部分参与了慢性RSD对NOR记忆检索的不利影响,但不参与NOR记忆的获取、巩固和再巩固。
{"title":"Role of Cannabinoid CB1, Receptor in Object Recognition Memory Impairment in Chronically Rapid Eye Movement Sleep-deprived Rats","authors":"Kaveh Shahveisi ,&nbsp;Seyedeh Marziyeh Hadi ,&nbsp;Hamed Ghazvini ,&nbsp;Mehdi Khodamoradi","doi":"10.24920/004087","DOIUrl":"https://doi.org/10.24920/004087","url":null,"abstract":"<div><h3>Objective</h3><p>We aimed to investigate whether antagonism of the cannabinoid CB<sub>1</sub> receptor (CB<sub>1</sub>R) could affect novel object recognition (NOR) memory in chronically rapid eye movement sleep-deprived (RSD) rats.</p></div><div><h3>Methods</h3><p>The animals were examined for recognition memory following a 7-day chronic partial RSD paradigm using the multiple platform technique. The CB<sub>1</sub>R antagonist rimonabant (1 or 3 mg/kg, i.p.) was administered either at one hour prior to the sample phase for acquisition, or immediately after the sample phase for consolidation, or at one hour before the test phase for retrieval of NOR memory. For the reconsolidation task, rimonabant was administered immediately after the second sample phase.</p></div><div><h3>Results</h3><p>The RSD episode impaired acquisition, consolidation, and retrieval, but it did not affect the reconsolidation of NOR memory. Rimonabant administration did not affect acquisition, consolidation, and reconsolidation; however, it attenuated impairment of the retrieval of NOR memory induced by chronic RSD.</p></div><div><h3>Conclusions</h3><p>These findings, along with our previous report, would seem to suggest that RSD may affect different phases of recognition memory based on its duration. Importantly, it seems that the CB<sub>1</sub>R may, at least in part, be involved in the adverse effects of chronic RSD on the retrieval, but not in the acquisition, consolidation, and reconsolidation, of NOR memory.</p></div>","PeriodicalId":35615,"journal":{"name":"Chinese Medical Sciences Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50176544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
基于m6A修饰SOCS2调控JAK/STAT通路探讨清热活血方治疗活动期RA临床与机制研究 基于m6A修饰SOCS2调控JAK/STAT通路探讨清热活血方治疗活动期RA临床与机制研究
Q2 Medicine Pub Date : 2023-01-01 DOI: 10.27658/d.cnki.gzzyy.2023.000058
张解玉
{"title":"基于m6A修饰SOCS2调控JAK/STAT通路探讨清热活血方治疗活动期RA临床与机制研究","authors":"张解玉","doi":"10.27658/d.cnki.gzzyy.2023.000058","DOIUrl":"https://doi.org/10.27658/d.cnki.gzzyy.2023.000058","url":null,"abstract":"","PeriodicalId":35615,"journal":{"name":"Chinese Medical Sciences Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142028033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
益气清解方对IgA肾病小鼠粘膜免疫应答中B淋巴细胞活化与归巢的影响 益气清解方对IgA肾病小鼠粘膜免疫应答中B淋巴细胞活化与归巢的影响
Q2 Medicine Pub Date : 2023-01-01 DOI: 10.27658/d.cnki.gzzyy.2023.000220
吴小聪
{"title":"益气清解方对IgA肾病小鼠粘膜免疫应答中B淋巴细胞活化与归巢的影响","authors":"吴小聪","doi":"10.27658/d.cnki.gzzyy.2023.000220","DOIUrl":"https://doi.org/10.27658/d.cnki.gzzyy.2023.000220","url":null,"abstract":"","PeriodicalId":35615,"journal":{"name":"Chinese Medical Sciences Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142031013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
粉防己与延胡索毛状根诱导体系及遗传转化体系的建立 粉防己与延胡索毛状根诱导体系及遗传转化体系的建立
Q2 Medicine Pub Date : 2023-01-01 DOI: 10.27658/d.cnki.gzzyy.2023.000191
张秀华
{"title":"粉防己与延胡索毛状根诱导体系及遗传转化体系的建立","authors":"张秀华","doi":"10.27658/d.cnki.gzzyy.2023.000191","DOIUrl":"https://doi.org/10.27658/d.cnki.gzzyy.2023.000191","url":null,"abstract":"","PeriodicalId":35615,"journal":{"name":"Chinese Medical Sciences Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142031136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
雷公藤红素纳米给药系统设计及光疗-化疗协同抗肿瘤研究 雷公藤红素纳米给药系统设计及光疗-化疗协同抗肿瘤研究
Q2 Medicine Pub Date : 2023-01-01 DOI: 10.27658/d.cnki.gzzyy.2023.000010
陈功森
{"title":"雷公藤红素纳米给药系统设计及光疗-化疗协同抗肿瘤研究","authors":"陈功森","doi":"10.27658/d.cnki.gzzyy.2023.000010","DOIUrl":"https://doi.org/10.27658/d.cnki.gzzyy.2023.000010","url":null,"abstract":"","PeriodicalId":35615,"journal":{"name":"Chinese Medical Sciences Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142027909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
转运蛋白CmABCB19和CmABCC10影响佛手果形发育的初步研究 转运蛋白CmABCB19和CmABCC10影响佛手果形发育的初步研究
Q2 Medicine Pub Date : 2023-01-01 DOI: 10.27658/d.cnki.gzzyy.2023.000135
张敏
{"title":"转运蛋白CmABCB19和CmABCC10影响佛手果形发育的初步研究","authors":"张敏","doi":"10.27658/d.cnki.gzzyy.2023.000135","DOIUrl":"https://doi.org/10.27658/d.cnki.gzzyy.2023.000135","url":null,"abstract":"","PeriodicalId":35615,"journal":{"name":"Chinese Medical Sciences Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142031135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
基于组学技术探究参芪补气颗粒改善慢性心衰能量代谢的调控作用 基于组学技术探究参芪补气颗粒改善慢性心衰能量代谢的调控作用
Q2 Medicine Pub Date : 2023-01-01 DOI: 10.27658/d.cnki.gzzyy.2023.000109
苗兰
{"title":"基于组学技术探究参芪补气颗粒改善慢性心衰能量代谢的调控作用","authors":"苗兰","doi":"10.27658/d.cnki.gzzyy.2023.000109","DOIUrl":"https://doi.org/10.27658/d.cnki.gzzyy.2023.000109","url":null,"abstract":"","PeriodicalId":35615,"journal":{"name":"Chinese Medical Sciences Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142028342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
莲苄基异喹啉类生物碱生物合成途径中甲基转移酶的鉴定与功能研究 莲苄基异喹啉类生物碱生物合成途径中甲基转移酶的鉴定与功能研究
Q2 Medicine Pub Date : 2023-01-01 DOI: 10.27658/d.cnki.gzzyy.2023.000114
俞越童
{"title":"莲苄基异喹啉类生物碱生物合成途径中甲基转移酶的鉴定与功能研究","authors":"俞越童","doi":"10.27658/d.cnki.gzzyy.2023.000114","DOIUrl":"https://doi.org/10.27658/d.cnki.gzzyy.2023.000114","url":null,"abstract":"","PeriodicalId":35615,"journal":{"name":"Chinese Medical Sciences Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142027985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Chinese Medical Sciences Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1